News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
236,898 Results
Type
Article (14418)
Company Profile (25)
Press Release (222455)
Section
Business (75232)
Career Advice (707)
Deals (12638)
Drug Delivery (30)
Drug Development (27300)
Employer Resources (20)
FDA (5397)
Job Trends (5229)
News (121201)
Policy (9720)
Tag
Academia (632)
Accelerated approval (2)
Adcomms (4)
Allergies (28)
Alliances (12407)
ALS (27)
Alzheimer's disease (362)
Antibody-drug conjugate (ADC) (50)
Approvals (5461)
Artificial intelligence (50)
Autoimmune disease (5)
Automation (1)
Bankruptcy (103)
Best Places to Work (4117)
BIOSECURE Act (1)
Biosimilars (38)
Biotechnology (23)
Bladder cancer (38)
Brain cancer (18)
Breast cancer (155)
Cancer (1036)
Cardiovascular disease (73)
Career advice (545)
Career pathing (2)
CAR-T (44)
CDC (6)
Cell therapy (120)
Cervical cancer (10)
Clinical research (23377)
Collaboration (206)
Compensation (148)
Complete response letters (2)
COVID-19 (683)
CRISPR (16)
C-suite (40)
Cystic fibrosis (21)
Data (1238)
Decentralized trials (1)
Depression (11)
Diabetes (140)
Diagnostics (1980)
Digital health (7)
Diversity (1)
Diversity, equity & inclusion (6)
Drug discovery (29)
Drug pricing (39)
Duchenne muscular dystrophy (36)
Earnings (50614)
Editorial (11)
Employer branding (5)
Employer resources (16)
Events (37930)
Executive appointments (103)
FDA (5914)
Friedreich's ataxia (2)
Frontotemporal dementia (4)
Funding (185)
Gene editing (34)
Generative AI (1)
Gene therapy (114)
GLP-1 (279)
Government (1118)
Grass and pollen (1)
Guidances (147)
Healthcare (5537)
Huntington's disease (14)
IgA nephropathy (9)
Immunology and inflammation (45)
Immuno-oncology (3)
Indications (9)
Infectious disease (741)
Inflammatory bowel disease (46)
Inflation Reduction Act (3)
Influenza (21)
Intellectual property (17)
Interviews (88)
IPO (7156)
IRA (15)
Job creations (1335)
Job search strategy (524)
Kidney cancer (4)
Labor market (22)
Layoffs (116)
Leadership (4)
Legal (2186)
Liver cancer (22)
Lung cancer (168)
Lymphoma (87)
Machine learning (2)
Management (4)
Manufacturing (72)
MASH (34)
Medical device (4238)
Medtech (4238)
Mergers & acquisitions (5710)
Metabolic disorders (311)
Multiple sclerosis (30)
NASH (6)
Neurodegenerative disease (36)
Neuropsychiatric disorders (9)
Neuroscience (560)
NextGen: Class of 2025 (1538)
Non-profit (1166)
Now hiring (8)
Obesity (144)
Opinion (49)
Ovarian cancer (35)
Pain (29)
Pancreatic cancer (42)
Parkinson's disease (47)
Partnered (4)
Patents (40)
Patient recruitment (31)
Peanut (14)
People (11444)
Pharmaceutical (9)
Pharmacy benefit managers (2)
Phase I (6292)
Phase II (9657)
Phase III (8858)
Pipeline (1009)
Policy (45)
Postmarket research (1172)
Preclinical (2526)
Press Release (25)
Prostate cancer (40)
Psychedelics (8)
Radiopharmaceuticals (74)
Rare diseases (96)
Real estate (1645)
Recruiting (7)
Regulatory (7072)
Reports (25)
Research institute (539)
Resumes & cover letters (111)
Rett syndrome (3)
RNA editing (4)
RSV (24)
Schizophrenia (28)
Series A (35)
Series B (27)
Sickle cell disease (17)
Special edition (8)
Spinal muscular atrophy (40)
Sponsored (7)
Startups (826)
Stomach cancer (2)
Supply chain (17)
Tariffs (15)
The Weekly (11)
Vaccines (222)
Venture capital (11)
Weight loss (98)
Women's health (7)
Worklife (3)
Date
Today (24)
Last 7 days (73)
Last 30 days (545)
Last 365 days (10811)
2025 (5760)
2024 (11769)
2023 (13130)
2022 (17173)
2021 (17520)
2020 (16450)
2019 (13136)
2018 (9727)
2017 (8680)
2016 (7204)
2015 (8937)
2014 (6895)
2013 (5789)
2012 (38164)
2011 (22663)
2010 (5610)
Location
Africa (255)
Alabama (14)
Arizona (54)
Arkansas (4)
Asia (14718)
Australia (2040)
California (2420)
Canada (751)
China (231)
Colorado (92)
Connecticut (112)
Delaware (84)
Europe (33920)
Florida (324)
Georgia (68)
Idaho (9)
Illinois (207)
India (4)
Indiana (132)
Iowa (2)
Japan (78)
Kansas (60)
Kentucky (13)
Louisiana (8)
Maine (26)
Maryland (267)
Massachusetts (1747)
Michigan (66)
Minnesota (130)
Missouri (26)
Montana (7)
Nebraska (7)
Nevada (30)
New Hampshire (22)
New Jersey (905)
New Mexico (3)
New York (668)
North Carolina (342)
North Dakota (3)
Northern California (1192)
Ohio (55)
Oklahoma (1)
Oregon (3)
Pennsylvania (534)
Puerto Rico (2)
Rhode Island (4)
South America (388)
South Carolina (8)
Southern California (904)
Tennessee (31)
Texas (365)
United States (8916)
Utah (63)
Virginia (50)
Washington D.C. (15)
Washington State (206)
Wisconsin (16)
236,898 Results for "13".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Simulations Plus Releases ADMET Predictor® 13
June 5, 2025
·
4 min read
Mergers & acquisitions
Lilly Validates Gene Editing Space With $1.3B Verve Buy, But Analysts Are Skeptical
The pending deal was rumored overnight after a report from the
Financial Times
, spurring analysts to speculate that if true, the entire gene editing space would see a boost at the markets.
June 17, 2025
·
3 min read
·
Annalee Armstrong
Press Releases
Bausch + Lomb Will Release Second-Quarter 2025 Financial Results on July 30 and Hold Investor Day on Nov. 13
June 30, 2025
·
1 min read
Press Releases
CareDx to Participate in Upcoming Investor Conferences - May 13, 2025
May 14, 2025
·
1 min read
Press Releases
Glaukos Announces Participation in Upcoming Investor Conferences - May 13, 2025
May 14, 2025
·
1 min read
Press Releases
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 13, 2025
June 16, 2025
·
1 min read
Press Releases
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 13, 2025
June 16, 2025
·
3 min read
Press Releases
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 13, 2025
June 16, 2025
·
3 min read
Press Releases
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 13, 2025
June 16, 2025
·
1 min read
Press Releases
GenSight Biologics Annual General Meeting on May 13, 2025
April 23, 2025
·
2 min read
1 of 23,690
Next
